Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Polyclonal Antibody

Anti-MGP Polyclonal Antibody

Catalog #:   PHC33201 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: ELISA, IHC, WB
Accession: P08493
Overview

Catalog No.

PHC33201

Species reactivity

Human, Mouse

Host species

Rabbit

Isotype

IgG

Clonality

Polyclonal

Immunogen

E. coli - derived recombinant Human MGP (Tyr20-Lys103).

Tested applications

ELISA: 1:4000-1:8000, IHC: 1:50-1:100, WB: 1:1000-1:4000

Target

MGLAP,MGP,Cell growth-inhibiting gene 36 protein,Matrix Gla protein

Purification

Purified by antigen affinity column.

Accession

P08493

Applications

ELISA, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Data Image
  • WESTERN BLOT
    Recombinant Protein lysates were subjected to SDS PAGE followed by western blot with MGP antibody (PHC33201) at 1 μg/ml.

    Lane 1: Recombinant protein

    Second Ab: Goat Anti-Rabbit IgG H&L Polyclonal antibody, HRP (PTB96431) at 0.1 μg/mL.

    Predict MW: 13 kDa
    Observed MW: 13 kDa
References

The impact of pregnancy on future health in Rheumatoid Arthritis: A systematic review of the literature., PMID:40209970

Shared mechanisms of enhanced plasmid maintenance and antibiotic tolerance mediated by the VapBC toxin:antitoxin system., PMID:39704502

Novel Interacting Partners of MGP-40, a Chitinase-Like Protein in Buffalo Mammary Epithelial Cells., PMID:39579292

Unravelling Transplant-Ineligible Newly Diagnosed Multiple Myeloma Treatment in Real-World Practice in Spain: The CARINAE Study., PMID:39458913

Co-opting templated aggregation to degrade pathogenic tau assemblies and improve motor function., PMID:39276772

Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study., PMID:39236556

Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trial., PMID:39038477

Grass pollen allergoids conjugated with mannan for subcutaneous and sublingual immunotherapy: a dose-finding study., PMID:38989287

Mosaic vaccine-induced antibody-dependent cellular phagocytosis associated with delayed HIV-1 viral load rebound post treatment interruption., PMID:38850529

Immunogenicity of 2 therapeutic mosaic HIV-1 vaccine strategies in individuals with HIV-1 on antiretroviral therapy., PMID:38782902

HIV Diagnostics and Vaccines: It Takes Two to Tango., PMID:38451247

Transsynaptic Degeneration of Retinal Ganglion Cells Following Lesions to Primary Visual Cortex in Marmosets., PMID:38306108

Preparation, characterization and immune response of chitosan‑gold loaded Myricaria germanica polysaccharide., PMID:38070794

Towards Novel HIV-1 Serodiagnostic Tests without Vaccine-Induced Seroreactivity., PMID:37222611

Muscadine grape (vitis rotundifolia) and wine polyphenols alleviated arthritis and restored the gut microbial composition in mice., PMID:36878329

Identification of biomarkers to stratify response to B-cell-targeted therapies in systemic lupus erythematosus: an exploratory analysis of a randomised controlled trial., PMID:36756239

Anti-SARS-CoV-2 antibodies following vaccination are associated with lymphocyte count and serum immunoglobulins in SLE., PMID:36631440

Population-based prevalence and incidence estimates of mixed connective tissue disease from the Manhattan Lupus Surveillance Program., PMID:36538873

Safety and Immunogenicity of Ad26-Vectored HIV Vaccine With Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-Uninfected Adults: A Phase 1/2a Study., PMID:36348617

Protection against Marburg Virus and Sudan Virus in NHP by an Adenovector-Based Trivalent Vaccine Regimen Is Correlated to Humoral Immune Response Levels., PMID:36016151

A BALB/c IGHV Reference Set, Defined by Haplotype Analysis of Long-Read VDJ-C Sequences From F1 (BALB/c x C57BL/6) Mice., PMID:35720344

Therapeutic efficacy of an Ad26/MVA vaccine with SIV gp140 protein and vesatolimod in ART-suppressed rhesus macaques., PMID:35585080

Checkpoint inhibitors in metastatic gastric and GEJ cancer: a multi-institutional retrospective analysis of real-world data in a Western cohort., PMID:35012477

Inhibition of arginase modulates T-cell response in the tumor microenvironment of lung carcinoma., PMID:34367736

Distinct patterns of disease activity over time in patients with active SLE revealed using latent class trajectory models., PMID:34321096

Targeted delivery of cytotoxic proteins to prostate cancer via conjugation to small molecule urea-based PSMA inhibitors., PMID:34290365

Engraftment of Bacteria after Fecal Microbiota Transplantation Is Dependent on Both Frequency of Dosing and Duration of Preparative Antibiotic Regimen., PMID:34209573

A new molecular classification to drive precision treatment strategies in primary Sjögren's syndrome., PMID:34112769

A 10-Gene Signature for Predicting the Response to Neoadjuvant Trastuzumab Therapy in HER2-Positive Breast Cancer., PMID:34052107

Ebola Virus Transmission Initiated by Relapse of Systemic Ebola Virus Disease., PMID:33789012

Preclinical Efficacy and Anti-Inflammatory Mechanisms of Action of the Bruton Tyrosine Kinase Inhibitor Rilzabrutinib for Immune-Mediated Disease., PMID:33674445

Nonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidate., PMID:33335092

Meeting report from the Prostate Cancer Foundation PSMA theranostics state of the science meeting., PMID:32865839

Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis., PMID:32726800

Protease-activation using anti-idiotypic masks enables tumor specificity of a folate receptor 1-T cell bispecific antibody., PMID:32581215

Targeted inhibition of activated protein C by a non-active-site inhibitory antibody to treat hemophilia., PMID:32532974

Matrix Gla protein maintains normal and malignant hematopoietic progenitor cells by interacting with bone morphogenetic protein-4., PMID:32322728

Alirocumab, evinacumab, and atorvastatin triple therapy regresses plaque lesions and improves lesion composition in mice., PMID:31843957

A vaccine-induced gene expression signature correlates with protection against SIV and HIV in multiple trials., PMID:31462510

Anti-PCSK9 antibodies inhibit pro-atherogenic mechanisms in APOE*3Leiden.CETP mice., PMID:31366894

Single-cell RNA sequencing reveals novel gene expression signatures of trastuzumab treatment in HER2+ breast cancer: A pilot study., PMID:31261495

Treatment of primary Sjögren's syndrome with ianalumab (VAY736) targeting B cells by BAFF receptor blockade coupled with enhanced, antibody-dependent cellular cytotoxicity., PMID:30826774

Peptide-based PET quantifies target engagement of PD-L1 therapeutics., PMID:30457978

Endothelial Cell-Specific Inactivation of TSPAN12 (Tetraspanin 12) Reveals Pathological Consequences of Barrier Defects in an Otherwise Intact Vasculature., PMID:30354230

Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy., PMID:30341058

A Case of Switch from C3 Glomerulonephritis to Proliferative Glomerulonephritis with Monoclonal IgG Deposits., PMID:30143498

Decreased expression of cell adhesion genes in cancer stem-like cells isolated from primary oral squamous cell carcinomas., PMID:29888653

Epidemiological and histological findings implicate matrix Gla protein in diastolic left ventricular dysfunction., PMID:29529056

Exploiting novel valve interstitial cell lines to study calcific aortic valve disease., PMID:29207136

Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors., PMID:29097494

Datasheet

Document Download

Anti-MGP Polyclonal Antibody.pdf

 

$ 170
Product specifications
50 μg 170 100 μg 280

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-MGP Polyclonal Antibody [PHC33201]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only